THE DISTRIBUTION AND SOME PHARMACOKINETIC PARAMETERS OF IVERMECTIN IN PIGS

被引:55
作者
SCOTT, EW [1 ]
MCKELLAR, QA [1 ]
机构
[1] UNIV GLASGOW,SCH VET,DEPT VET PHARMACOL,GLASGOW G61 1QH,SCOTLAND
关键词
IVERMECTIN; PHARMACOKINETICS; PIGS; RESIDUES;
D O I
10.1007/BF01839011
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Ivermectin was injected subcutaneously into five pigs at the usual dose rate of 300-mu-g/kg and found to distribute well to all tissues and body fluids which were sampled 24 h post-injection. Ivermectin was detected in the contents and mucus at all levels of the gastrointestinal tract. The drug was excreted in bile, with high concentrations of the drug in the intestines and faeces. High concentrations of ivermectin were measured in skin, ears and ear wax, suggesting that the drug should be effective in the treatment of ectoparasitic infestations, particularly ear mites. The high lipid solubility of the drug may explain the high concentrations found in ear wax and skin. Ivermectin was also detected in the body fluids and tissues of an untreated pig penned with the treated animals. Direct contact appeared to be necessary for transfer of ivermectin from the treated to the untreated pig but coprophagia or urine drinking is a possible explanation. The pharmacokinetics of ivermectin administered subcutaneously at a dose rate of 300-mu-g/kg to six pigs were studied. There was marked individual variation in the pharmacokinetics of ivermectin. In one pig the area under the plasma concentration-time curve was particularly high. This may reflect individual variation in uptake and excretion of the drug. The mean elimination half-life of the drug was 35.2 h, suggesting that the drug is cleared slowly from pigs with drug detectable in plasma for 6-10 days. This persistence should allow a short period of protection before re-infection with parasites.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 10 条
[1]  
Benz G. W., 1989, Ivermectin and abamectin., P215
[2]  
BOGAN JA, 1988, J VET PHARMACOL THER, V11, P260, DOI 10.1111/j.1365-2885.1988.tb00151.x
[3]   METABOLIC DISPOSITION OF IVERMECTIN IN SWINE [J].
CHIU, SHL ;
SESTOKAS, E ;
TAUB, R ;
GREEN, ML ;
BAYLIS, FP ;
JACOB, TA ;
LU, AYH .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1990, 38 (11) :2079-2085
[4]  
Fink D. W., 1989, Ivermectin and abamectin., P113
[5]  
JACOB TA, 1983, RECENT DEV CONTROL A, P56
[6]  
LO PKA, 1985, VET RES COMMUN, V9, P251
[7]   THE PHARMACOKINETICS OF IVERMECTIN AFTER ORAL AND SUBCUTANEOUS ADMINISTRATION TO SHEEP AND HORSES [J].
MARRINER, SE ;
MCKINNON, I ;
BOGAN, JA .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1987, 10 (02) :175-179
[8]  
SCHNITZERLING HJ, 1985, J ASSOC OFF ANA CHEM, V68, P36
[9]   CSTRIP, A FORTRAN-4 COMPUTER-PROGRAM FOR OBTAINING INITIAL POLYEXPONENTIAL PARAMETER ESTIMATES [J].
SEDMAN, AJ ;
WAGNER, JG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (07) :1006-1010
[10]   PHARMACOKINETICS OF IVERMECTIN ADMINISTERED INTRAVENOUSLY TO CATTLE [J].
WILKINSON, PK ;
POPE, DG ;
BAYLIS, FP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (10) :1105-1107